Hugh Rosen

Insider Reports History

Location
San Diego, CA
Signature
/s/ Christopher Aker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Hugh Rosen:

Company Role Class Num Shares Value Price $ Report Date Ownership
Regulus Therapeutics Inc. Director Common Stock 0 $0 $7.87 25 Jun 2025 Direct
Regulus Therapeutics Inc. Director Stock Option 0 25 Jun 2025 Direct

Insider Reports Filed by Hugh Rosen

Symbol Company Period Transactions Value $ Form Type Role Filing Time
RGLS Regulus Therapeutics Inc. 25 Jun 2025 10 $0 4 Director 27 Jun 2025, 17:09
RGLS Regulus Therapeutics Inc. 30 Apr 2025 1 $0 4 Director 30 Apr 2025, 16:30
RGLS Regulus Therapeutics Inc. 20 May 2024 1 $0 4 Director 21 May 2024, 16:23
RGLS Regulus Therapeutics Inc. 16 May 2024 1 $0 4 Director 17 May 2024, 16:44
RGLS Regulus Therapeutics Inc. 10 Aug 2023 1 $0 4 Director 14 Aug 2023, 17:34
RGLS Regulus Therapeutics Inc. 13 Jun 2023 1 $0 4 Director 13 Jun 2023, 16:54
RGLS Regulus Therapeutics Inc. 09 Jun 2022 1 $0 4 Director 10 Jun 2022, 16:16
RGLS Regulus Therapeutics Inc. 14 Jun 2021 1 $0 4 Director 15 Jun 2021, 16:45